or Try an Advanced Search...

    Technical Analysis for OPTN - OptiNose, Inc.

    Grade Last Price % Change Price Change
    F 1.16 11.06% 0.12
    OPTN closed up 0.97 percent on Wednesday, May 8, 2024, on 17 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: May 9
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical OPTN trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 11.06%
    Narrow Range Bar Range Contraction 11.06%
    Wide Bands Range Expansion 11.06%
    Wide Bands Range Expansion 12.14%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.32%
    Crossed Above 20 DMA Bullish 1.32%
    Wide Bands Range Expansion 1.32%
    Gapped Up Strength 1.32%
    New Uptrend Bullish 14.36%
    Wide Bands Range Expansion 14.36%
    Older End-of-Day Signals for OPTN ...

       Recent Intraday Alerts

    Alert Time
    Up 10% 14 minutes ago
    Up 1 ATR 14 minutes ago
    60 Minute Opening Range Breakout about 1 hour ago
    Up 5% about 1 hour ago
    Up 3% about 1 hour ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    OPTN Chart by TradingView
    Basic chart:

    Profile

    OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Clinical Medicine Pharmaceutical Disease Organ Systems Inflammation Allergy Respiratory Therapy Polyp Sinus Glucocorticoids Chronic Rhinosinusitis Corticosteroid Nasal Spray Sinusitis Fluticasone Nasal Polyps

    Is OPTN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 5 Recent uptick might appease OptiNose, Inc. (NASDAQ:OPTN) institutional owners after losing 50% over the past year
    May 3 Will Gain Therapeutics, Inc. (GANX) Report Negative Q1 Earnings? What You Should Know
    May 2 Will OptiNose (OPTN) Report Negative Q1 Earnings? What You Should Know
    Apr 25 Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Apr 25 Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
    Apr 6 OptiNose (NASDAQ:OPTN) shareholders have endured a 87% loss from investing in the stock five years ago
    Apr 4 Optinose to Present at the Needham Virtual Healthcare Conference
    Mar 16 OptiNose granted FDA nod to expand labeling for sinusitis therapy
    Mar 15 XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
    Mar 10 US$3.00: That's What Analysts Think OptiNose, Inc. (NASDAQ:OPTN) Is Worth After Its Latest Results
    See more OPTN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.1
    52 Week Low 0.8
    Average Volume 1,318,039
    200-Day Moving Average 1.29
    50-Day Moving Average 1.38
    20-Day Moving Average 1.00
    10-Day Moving Average 0.95
    Average True Range 0.11
    RSI (14) 46.24
    ADX 25.93
    +DI 33.09
    -DI 21.74
    Chandelier Exit (Long, 3 ATRs) 1.02
    Chandelier Exit (Short, 3 ATRs) 1.14
    Upper Bollinger Bands 1.24
    Lower Bollinger Band 0.75
    Percent B (%b) 0.59
    BandWidth 49.13
    MACD Line -0.09
    MACD Signal Line -0.13
    MACD Histogram 0.0367
    Fundamentals Value
    Market Cap 116.8 Million
    Num Shares 112 Million
    EPS -0.38
    Price-to-Earnings (P/E) Ratio -2.74
    Price-to-Sales 2.09
    Price-to-Book 24.26
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.09
    Resistance 3 (R3) 1.08 1.06 1.08
    Resistance 2 (R2) 1.06 1.05 1.06 1.07
    Resistance 1 (R1) 1.05 1.04 1.06 1.06 1.07
    Pivot Point 1.03 1.03 1.03 1.03 1.03
    Support 1 (S1) 1.02 1.02 1.03 1.03 1.01
    Support 2 (S2) 1.00 1.01 1.00 1.01
    Support 3 (S3) 0.99 1.00 1.00
    Support 4 (S4) 1.00